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ABSTRACT 
Intrinsic or acquired resistance of lung cancer (LC) to chemo- or radiotherapy (CT/RT) 
limits the treatment effectiveness, which, in turn contributes to tumor progression and 
ultimately increases the mortality rate of the LC patients. Although resistance to tumor 
treatment is a multifactorial event for which several factors were identified, still many 
critical features underlying the mechanisms of resistance remain elusive. One of the main 
mechanisms, evasion of apoptosis, was recently shown to be modulated by miRNAs, an 
emerging class of important regulators of various biological processes, including apoptotic 
cell death that essentially contributes in CT/RT response. Thus miRNAs, as oncomiRs, 
might regulate anti-apoptotic protein’s expression or suppress a pro-apoptotic cellular 
response. In the current thesis we therefore, analyzed the role of miRNAs and the core 
proteins involved in their biogenesis in LC cells response to CT/RT.  
The paramount question we addressed was to infer whether the expression of core proteins 
involved in miRNA biogenesis can be associated with LC resistance to RT and if so, can 
we sensitize resistant LC cells to RT upon silencing of these proteins. Detailed analysis of a 
panel of SCLC and NSCLC cell lines revealed that the major proteins of miRNA 
biogenesis machinery, Drosha and Dicer, were expressed at higher levels in RT resistant 
LC cells as compared to RT sensitive counterparts. However, knock-down of these proteins 
by siRNA appeared to be insufficient to sensitize for RT. Moreover, knock-down of 
downstream components of miRNA biogenesis pathway, Ago-2 and TSN, did not either 
enhance the sensitivity of NSCLC cells to ionizing radiation. These data suggest that RT 
resistance in LC cells cannot be reverted by modulation of a single component of the 
miRNA biogenesis machinery. Next, to find out whether miRNA expression can affect RT 
sensitivity of LC cells, a global miRNA profiling was performed using the same panel of 
SCLC and NSCLC cell lines with different RT sensitivity. We observed that miRNA-214 
had a higher expression in radioresistant NSCLC cells as compared to their sensitive 
counterparts. Considering miRNA-214 as an important modifier of LC cells radioresistance 
capacity, expression of this miRNA was silenced in radioresistant and overexpressed in 
sensitive NSCLC cells, respectively. Indeed, knock-down of miRNA-214 in radioresistant 
NSCLC cells increased their RT sensitivity and these cells underwent senescence after 
irradiation. Importantly, overexpression of miRNA-214 in radiosensitive NSCLCs 
protected them from RT-induced apoptosis, an effect that in part was mediated by 
p38MAPK as downregulation of this kinase reversed the protective response of miRNA-
214 overexpression.  
Finally, to determine the key modifiers of LC CT resistance, we observed that 
downregulation of an evolutionally conserved multifunctional protein TSN increased the 
NSCLC cell death response either alone or in combination with CT drugs. A higher 
expression of TSN was detected in NSCLC cell lines than in normal lung fibroblast cells. 
Gene expression profiling upon silencing of TSN revealed that TSN likely contributes to 
NSCLC CT resistance by regulating expression of several tumor survival genes, such as 
S100A11, ATP6V1F, and MDC1, and simultaneously suppressing many of pro-apoptotic 
genes e.g., BNIP3, DRAM1, PDCD4, BCL2L13, and LAMP2 that eventually compromise 
tumor ability to undergo apoptosis. Altogether this suggests a potential contribution of high 
TSN expression towards LC malignancy and a CT resistant phenotype. 
In conclusion, in this study, we demonstrate the role of some miRNAs and the regulators of 
their biogenesis in LC therapy response. It is anticipated that further understanding of their 
functional impacts on mechanism(s) of resistance of LC cells to the current treatment 
modalities will generate novel therapy approaches as well as biomarkers of treatment 
response of this tumor malignancy. ISBN 978-91-7549-027-4. 
